Harvard Bioscience, Inc.
HBIO
$7.08
$0.111.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.91M | -3.42M | -2.85M | -1.23M | -2.28M |
| Total Depreciation and Amortization | 1.38M | 1.35M | 1.35M | 1.32M | 1.62M |
| Total Amortization of Deferred Charges | 497.00K | 446.00K | 624.00K | 357.00K | 210.00K |
| Total Other Non-Cash Items | 373.00K | 172.00K | 1.70M | 344.00K | 422.00K |
| Change in Net Operating Assets | 990.00K | 794.00K | -918.00K | 290.00K | 2.79M |
| Cash from Operations | 325.00K | -662.00K | -96.00K | 1.08M | 2.76M |
| Capital Expenditure | -688.00K | -426.00K | -449.00K | -207.00K | -89.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -228.00K | -194.00K | -150.00K | -141.00K | -144.00K |
| Cash from Investing | -916.00K | -620.00K | -599.00K | -348.00K | -233.00K |
| Total Debt Issued | -- | -- | 40.00M | -- | -- |
| Total Debt Repaid | -- | -- | -34.35M | -1.00M | -1.00M |
| Issuance of Common Stock | 0.00 | 150.00K | 1.00K | 0.00 | 46.00K |
| Repurchase of Common Stock | -36.00K | -30.00K | -57.00K | -24.00K | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.00K | -129.00K | -3.15M | -254.00K | -304.00K |
| Cash from Financing | -38.00K | -9.00K | 2.45M | -1.28M | -1.26M |
| Foreign Exchange rate Adjustments | 34.00K | -225.00K | 43.00K | -83.00K | 632.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -595.00K | -1.52M | 1.80M | -625.00K | 1.90M |